在VersKiK的案例研究:研究小儿癌症幸存者的途径的方法方法方法
E Aleshchenko1, T Langer2, G Calaminus3
1Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University, Magdeburg, Germany. ekaterina.aleshchenko@med.ovgu.de.
BMC medical research methodology
|December 2, 2025
概括
这项研究探讨了儿童癌症幸存者的"幸存者途径",开发案例研究以改善长期随访护理,并解决儿童癌症幸存者的晚期影响.
科学领域:
- 在瘤学瘤学.
- 幸存者护理 幸存者护理
- 医疗保健系统 医疗保健系统
背景情况:
- 儿童和青少年癌症的生存率增加需要强有力的后续护理.
- 儿童癌症幸存者面临癌症及其治疗的长期健康风险.
- 系统的后续对早期检测和晚期影响的管理至关重要.
研究的目的:
- 为了检查现实生活中的儿科癌症生存情况.
- 确定当前后续护理结构需要改进的领域.
- 为VersKiK研究提供信息,以提高儿童癌症幸存者护理.
主要方法:
- 进行了19名参与者对后续预约的观察.
- 与儿童癌症幸存者和护理人员进行了36次叙事采访.
- 采用了感应式叙事方法和案例研究开发,其次是重点小组.
主要成果:
- 开发了两个不同的案例研究,说明了儿科癌症生存途径.
- 一个案例研究详细介绍了一个成年幸存者的旅程.
- 第二个案例研究侧重于一个在儿科和成人护理之间过渡的幸存者.
结论:
- 案例研究为讨论改善幸存者护理提供了基础.
- 与医疗保健提供者和患者倡导者的焦点小组告知了潜在的改进.
- 这些发现旨在优化儿童癌症后续护理的组织.
相关概念视频
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Kaplan-Meier Approach
537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Actuarial Approach
278
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
278
Mouse Models of Cancer Study
6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


